EDGAR Filing Documents for 0001193125-22-218078

Form 8-K - Current report:

SEC Accession No. 0001193125-22-218078

Filing Date

2022-08-11

Accepted

2022-08-11 08:54:04

Documents

Period of Report

2022-08-11

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d365414d8k.htm iXBRL	8-K	28081
2	EX-99.1	d365414dex991.htm	EX-99.1	59785
3	EX-99.2	d365414dex992.htm	EX-99.2	17225
7	GRAPHIC	g365414ex99_2s10g1.jpg	GRAPHIC	313963
8	GRAPHIC	g365414ex99_2s11g1.jpg	GRAPHIC	293111
9	GRAPHIC	g365414ex99_2s12g1.jpg	GRAPHIC	327727
10	GRAPHIC	g365414ex99_2s13g1.jpg	GRAPHIC	245113
11	GRAPHIC	g365414ex99_2s14g1.jpg	GRAPHIC	286795
12	GRAPHIC	g365414ex99_2s15g1.jpg	GRAPHIC	243552
13	GRAPHIC	g365414ex99_2s16g1.jpg	GRAPHIC	313988
14	GRAPHIC	g365414ex99_2s1g1.jpg	GRAPHIC	379514
15	GRAPHIC	g365414ex99_2s2g1.jpg	GRAPHIC	360455
16	GRAPHIC	g365414ex99_2s3g1.jpg	GRAPHIC	311154
17	GRAPHIC	g365414ex99_2s4g1.jpg	GRAPHIC	231926
18	GRAPHIC	g365414ex99_2s5g1.jpg	GRAPHIC	175625
19	GRAPHIC	g365414ex99_2s6g1.jpg	GRAPHIC	289874
20	GRAPHIC	g365414ex99_2s7g1.jpg	GRAPHIC	608672
21	GRAPHIC	g365414ex99_2s8g1.jpg	GRAPHIC	278050
22	GRAPHIC	g365414ex99_2s9g1.jpg	GRAPHIC	261529
23	GRAPHIC	g365414g0811042045299.jpg	GRAPHIC	3021
	Complete submission text file	0001193125-22-218078.txt		7025341

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	labp-20220811.xsd	EX-101.SCH	2869
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	labp-20220811_lab.xml	EX-101.LAB	17979
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	labp-20220811_pre.xml	EX-101.PRE	11267
25	EXTRACTED XBRL INSTANCE DOCUMENT	d365414d8k_htm.xml	XML	3379

Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060

Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844

Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)